About
Daisy Wolf is a partner at Andreessen Horowitz, where she leads investments in health technology.
Daisy serves on the boards of Function Health, Truemed, Protege, Slingshot AI, Telepatia, and Ease Health. Her broader portfolio includes Pomelo Care, Fortuna Health, Knownwell, Milu Health, and Ferry Health, among others.
Prior to joining Andreessen Horowitz, Daisy worked at Meta in the Global Business Group, where she led growth initiatives focused on government and politics. She has also held operating roles at startups and covered the technology sector at a hedge fund.
Daisy holds a JD from Yale Law School, an MBA from the Stanford Graduate School of Business, and a BA from Yale College, where she graduated Phi Beta Kappa.
Latest Content by Daisy
Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
Function Health Series B: Launching the Medical Intelligence Era
Why Tech Must Disrupt Healthcare Now
Daisy on X
Join the conversationWant More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.